Gerson Lehrman Group - Intelligently Connecting Institutions and Expertise.

Study Group: Former C-Level Executives in the Healthcare Council in Member Programs

Council Members in this Study Group: 289

This study group may include physicians, care providers, and researchers specializing in internal medicine, cardiology, oncology, dermatology, emergency medicine, family medicine, neurology, obstetrics-gynecology, psychiatry, radiology, nursing, optometry, genetics, and mental health. It may also include experts knowledgeable on diagnostic labs, disease management, medical devices, long term care, surgery centers, health management, pharma, and biotechnology, among others.

Contact Gerson Lehrman Group to survey or consult with members of this Study Group

Leading institutions connect with members of this Study Group through GLG

Leading Experts in this Study Group

Kurt Orlofski, President and COO, G & W Laboratories IncKurt Orlofski

President and COO
G & W Laboratories Inc
What is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

Kurt Orlofski, CPA, CMA, is President and COO at G & W Laboratories. Mr. Orlofski was previously, President of Wockhardt USA. Wockhardt is a global leader in pharmaceuticals and biotechnology. Previously, Mr. Orlofski was President and Chief Executive...

1 news post(s)
Michael Sosnowik

President
MSS Consultants, LLC
What is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

Michael Sosnowik, PD, Pharmacist and former C-Level executive in pharma distribution, is the President of MSS Consultants, an independent consulting firm to pharmaceutical manufacturers, distributors as well as managed care providers, in New York, since...

4 news post(s)
Robert Dondes

Independent Consultant
Robert Dondes, Consultant
What is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

Robert Dondes is an Independent Consultant based in the mid-Atlantic United States, with headquarters in Maryland. His private practice focuses on managed care, health insurance, strategic analysis, and operational improvement. Mr. Dondes is affiliated...

2 event(s)
Mitchell Glass

Consultant
Mitchell Glass
What is a GLG Educator?|GLG Educators have qualified for GLG Member Programs and are therefore eligible to participate in ongoing in-depth consulting projects with GLG clients.

Mitchell Glass, MD, is a Consultant to start-up pharmaceutical and device companies. He is currently CEO and Director of AVATAR Biosystems. Dr. Glass was previously Senior Vice President and Chief Scientific Officer of the University City Science Center...

GLG NewsSM Analyses by this Study Group's Leading Experts(?)

Opinions and analyses expressed in GLG News are solely those of the author. See the Terms of Use for details.

Lupin acquisition in Japan a positive

October 16, 2007

Analysis by:Kurt Orlofski, President and COO,

Indian Drug Maker Lupin to Acquire Kyowa Pharmaceutical | www.pipelinereview.com

Japan is the second largest generic market in the world. Kyowa Pharmaceuticals has a real presence in the Japanese pharmaceutical market. Allows Kyowa to leverage low cost Indian manufacturing while Lupin gains a large and growing market for distribution.

Pill splitting

June 19, 2007

Analysis by:Michael Sosnowik, President,

'Pill Splitting' Cuts Drug Costs for Patients, Health Plans | www.forbes.com

The article glossed over issues such as pharmacist/pharmacy involvement, tablet scoring, and narrow thereapeutic range drugs, all of which can can profound impact into this practice.

DexCom

June 7, 2007

Analysis by:Michael Sosnowik, President,

DexCom Receives FDA Approval For 7-Day STS Continuous Glucose Monitoring System | www.medicaldesignonline.com

cost ease of use

Lybrel

June 7, 2007

Analysis by:Michael Sosnowik, President,

FDA Clears Wyeth Contraceptive Pill | online.wsj.com

-side effect profile -3rd party reimbursement -patient cost

wyeth

June 7, 2007

Analysis by:Michael Sosnowik, President,

FDA Clears Wyeth Contraceptive Pill | online.wsj.com

The side effect profile and impact will be the key indicator whether this product is as successful as it can be.

View All GLG News by members of this Study Group

Members in this Study Group include these company types:

  • Consultancy, Healthcare-Focused
  • Individual/Small Consultancy
  • Consultancy, Pharma-Focused
  • Strategic Management
  • Medical Device Consultancy

Members in this Study Group often have these job titles:

  • President
  • Owner
  • Principal
  • Consultant
  • Director
  • Partner

Related Study Groups

Study Group Name No. Members
Former C-level Executives in Member Programs 2258
Former C-level Executives at Large Companies ($500M+ in Sales) Who Are in Member Programs 2553
Medical Tourism Experts 358
Generic Drug Economic Experts 766
Ambulatory Surgery Center Experts 134
Economic Experts on Managed Care 714
CIOs, CTOs, and CISOs within past 2 years in GLG Member Programs 246
Managed Care Experts 669

GLG Live Meetings with this Study Group's Leading Experts (?)

July 26, 2006 | Boston

GLGi: The Future of Managed Care

July 26, 2006 | New York

GLGi: The Future of Managed Care

GLG Webcasts & Teleconferences

Leading Experts in Former C-Level Executives in the Healthcare Council in Member Programs have not participated in any GLG webcasts.

View All GLG Webcasts & Teleconferences in Healthcare